NCT00878553View on ClinicalTrials.gov

Study of Sleep-maintenance Activity of 3 Doses of SKP-1041

PHASE2CompletedINTERVENTIONAL

Enrollment

67

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

August 31, 2011

Conditions

Sleep DisorderPrimary Insomnia

Interventions

DRUG

placebo

tablet at bedtime

DRUG

SKP-1041 (experimental formulation of zaleplon)

tablet at bedtime

Sponsors

Collaborators (1)

INC Research Limited

All Listed Sponsors

collaborator

INC Research Limited

INDUSTRY

lead

Somnus Therapeutics, Inc.

INDUSTRY

NCT00878553 - Study of Sleep-maintenance Activity of 3 Doses of SKP-1041 | Biotech Hunter | Biotech Hunter